advanced search

Welcome: Guest

log in

Covidien Ltd.Tyco Healthcare Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 52
ISBN Number not applicable
Product Code GMD04862
Price

£505.00
approximately: $750 | €594

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Covidien Ltd.Tyco Healthcare's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Cardiovascular Devices
    • 2.5 Industry Outlook - Anesthesia and Respiratory Devices
    • 2.6 Industry Outlook - Hospital Supplies
    • 2.7 Industry Outlook - In Vitro Diagnostics
    • 2.8 SWOT Snapshot
  • 3 Covidien Ltd./Tyco Healthcare Pipeline Products
    • 3.1 Covidien Ltd./Tyco Healthcare Product Pipeline Analysis
      • 3.1.1 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
      • 3.1.2 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
      • 3.1.3 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
      • 3.1.4 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary
    • 3.2 PleuraSeal Lung Sealant System
      • 3.2.1 Product Description
      • 3.2.2 Product Status
      • 3.2.3 Product Milestone
    • 3.3 Sandman Intro CPAP Device
      • 3.3.1 Product Description
      • 3.3.2 Product Status
      • 3.3.3 Product Milestone
    • 3.4 Contrast Delivery System
      • 3.4.1 Product Description
      • 3.4.2 Product Status
      • 3.4.3 Product Milestone
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Imaging Solutions
      • 4.2.1 Overview
      • 4.2.2 Financials
      • 4.2.3 Capital Expenditure
      • 4.2.4 Market View
      • 4.2.5 Key Strategies
    • 4.3 Medical Devices
      • 4.3.1 Overview
      • 4.3.2 Financials
      • 4.3.3 Capital Expenditure
      • 4.3.4 Market View
      • 4.3.5 Key Strategies
    • 4.4 Medical Supplies
      • 4.4.1 Overview
      • 4.4.2 Financials
      • 4.4.3 Capital Expenditure
      • 4.4.4 Market View
      • 4.4.5 Key Strategies
    • 4.5 Pharmaceutical Products
      • 4.5.1 Overview
      • 4.5.2 Financials
      • 4.5.3 Capital Expenditure
      • 4.5.4 Market View
      • 4.5.5 Key Strategies
    • 4.6 Retail Products
      • 4.6.1 Overview
      • 4.6.2 Financials
      • 4.6.3 Capital Expenditure
      • 4.6.4 Market View
      • 4.6.5 Key Strategies
    • 4.7 Major Products and Services
      • 4.7.1 Overview
  • 5 History
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
    • 10.2 Other Locations & Subsidiaries
  • 11 Financial Deals Landscape
    • 11.1 Acquisition
      • 11.1.1 Covidien Acquires Tissue Science Laboratories
      • 11.1.2 Covidien Acquires Scandius Biomedical
    • 11.2 Debt Offerings
      • 11.2.1 Covidien International Finance Completes Private Placement Of $2,750 Million
    • 11.3 Partnership
      • 11.3.1 Covidien Signs An Agreement With Allergan
      • 11.3.2 Covidien And BioSynthema Enter Into Licensing Agreement
  • 12 Recent Developments
    • 12.1 Strategy and Business Planning
      • 12.1.1 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
    • 12.2 Financial Announcements
      • 12.2.1 May 06, 2008: Covidien Declares Q2 Fiscal 2008 Results
      • 12.2.2 Apr 09, 2008: Covidien To Declare Q2 2008 Results
      • 12.2.3 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
      • 12.2.4 Mar 18, 2008: Covidien Declares Quarterly Dividend
      • 12.2.5 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
      • 12.2.6 Jan 15, 2008: Covidien Declares Quarterly Dividend
      • 12.2.7 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
      • 12.2.8 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
      • 12.2.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
      • 12.2.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
    • 12.3 Other Significant Developments
      • 12.3.1 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
  • 13 Appendix
    • 13.1 Methodology
      • 13.1.1 Coverage
      • 13.1.2 Secondary Research
      • 13.1.3 Primary Research
      • 13.1.4 Expert Panel Validation
    • 13.2 Contact Us
    • 13.3 About Global Markets Direct
    • 13.4 Disclaimer
  • List of Tables
    • Table 1: Covidien Ltd./Tyco Healthcare,Key Facts, 2007
    • Table 2: Covidien Ltd./Tyco Healthcare Pipeline Products by Equipment Type
    • Table 3: Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
    • Table 4: Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
    • Table 5: Covidien Ltd./Tyco Healthcare Pipeline Products By News Summaries
    • Table 6: Covidien Ltd./Tyco Healthcare, Key Employees, 2007
    • Table 7: Covidien Ltd./Tyco Healthcare, Other Locations
    • Table 8: Covidien Ltd./Tyco Healthcare, Subsidiaries
  • List of Figures
    • Figure 1: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
    • Figure 2: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
    • Figure 3: Global Markets Direct Methodology